Instalab

Hazel Pollen (Cor a 1.0103) IgE Test Blood

See whether your seasonal symptoms or oral itching after raw fruits and nuts trace back to birch-related tree pollen.

Should you take a Hazel Pollen (Cor a 1.0103) IgE test?

This test is most useful if any of these apply to you.

Sneezing Through Spring
If your symptoms peak when trees bud, this test can confirm whether birch-family tree pollen is what your immune system is reacting to.
Mouth Itches After Raw Fruits or Nuts
If your lips, tongue, or throat tingle after raw apples, hazelnuts, peaches, or carrots, this test can identify the pollen-food cross-reaction behind it.
Living With Atopic Dermatitis or Asthma
If you have allergic skin or airway disease, this component test helps map which tree pollen proteins are driving your sensitization profile.
Considering Allergy Immunotherapy
If you are weighing allergen shots or sublingual immunotherapy, this test pinpoints the molecules driving your allergy so treatment can be matched to your profile.

About Hazel Pollen (Cor a 1.0103) IgE

If your nose runs in early spring, your eyes water around budding trees, or your mouth tingles after biting into a raw apple, hazelnut, or carrot, this test can help explain why. It pinpoints whether your immune system has built antibodies against a single protein in hazel pollen, the kind of protein that birch, alder, and hazel trees all share.

That distinction matters because a positive result usually points to pollen-driven allergy and mild food cross-reactions, not to a dangerous nut allergy. Knowing which pattern you have can change how you handle tree pollen season, whether you need to avoid raw plant foods, and whether allergy immunotherapy is worth considering.

What This Test Actually Measures

Cor a 1.0103 is a single protein from hazel pollen. It belongs to a family of proteins called PR-10 (pathogenesis-related class 10), which look almost identical across birch, alder, and hazel trees. Because they look so similar to your immune system, antibodies built against one of them often react to the others. The test measures IgE (immunoglobulin E), the antibody type that drives classic allergic reactions like sneezing, itching, and hives.

A positive result tells you that your immune system has been sensitized to this pollen family. It does not, on its own, prove that you will have symptoms. The link between sensitization and real-world reactions has to be made by matching the result to what your body actually does during pollen season or after specific foods.

Why This Test Is Useful: Pollen-Food Syndrome

Many people who are allergic to birch pollen develop oral itching, lip swelling, or throat scratchiness after eating raw hazelnut, apple, pear, peach, cherry, carrot, or celery. This pattern is called pollen-food syndrome, and it happens because the PR-10 protein in the food looks like the PR-10 protein in the pollen. Your antibodies see the food and react.

Studies in birch-pollen-allergic adults found that this kind of cross-reactive food allergy is common and often persists year-round, not just during pollen season. Reactions are usually limited to the mouth and throat, because the PR-10 protein breaks down quickly when cooked or digested. That is why most people with this sensitization tolerate roasted hazelnuts or baked apple pie even when raw versions cause symptoms.

Respiratory Allergy and Atopic Dermatitis

In adults with atopic dermatitis (chronic itchy skin inflammation), Cor a 1.0103 was one of the most frequently positive pollen molecules tested, alongside birch Bet v 1 and alder Aln g 1. In that group of 100 patients, high IgE to these PR-10 pollens clustered with more severe skin disease and with coexisting asthma and hay fever. The same pattern shows up across multiple molecular allergy studies: PR-10 pollen IgE tracks with respiratory allergy in regions where birch, alder, and hazel grow.

If you live in a temperate climate with birch trees and you have unexplained spring symptoms, this single component test can confirm whether tree pollen is the driver, even before broader testing or skin prick testing.

What It Does Not Tell You: Severe Hazelnut Allergy

This is the most important caveat. A positive Cor a 1.0103 result does not mean you have a dangerous, anaphylactic hazelnut allergy. The pollen-related PR-10 protein is heat-sensitive and breaks down in the stomach, which is why reactions are usually mild. True systemic hazelnut allergy, the kind that can cause throat closing or low blood pressure, is driven by entirely different proteins: Cor a 9 and Cor a 14, which are heat-stable storage proteins in the nut itself.

Meta-analyses in children have shown that IgE to Cor a 9 and Cor a 14 has much higher specificity for clinically meaningful hazelnut allergy, while Cor a 1 is sensitive but produces many positives in people who eat hazelnut without trouble. In adults, even component testing cannot fully replace a supervised oral food challenge when serious hazelnut allergy is being ruled in or out.

Reconciling the Apparent Contradiction

Reading the above, you might wonder how a positive nut-related test can mean something mild. The resolution is that Cor a 1.0103 is not a general hazelnut allergy marker. It is a marker of birch-family pollen sensitization that happens to cross-react with the same protein in hazelnut and a long list of raw plant foods. Two people can both test positive: one has only spring sniffles and itchy oral reactions to raw apples, while another has classic tree pollen rhinitis with no food symptoms at all. Risk of severe reactions to nuts is carried by different proteins entirely, which is why the storage protein components matter for that question.

Cross-Reactivity Within the Tree Pollen Family

The PR-10 protein in birch (called Bet v 1) is the original sensitizer for most people. From there, IgE cross-reacts to the homologous proteins in alder and hazel. Studies of tree-pollen-allergic patients found that most of those allergic to one Fagales-family tree pollen also reacted to the others, because the major allergens share so much structural similarity.

This means a positive Cor a 1.0103 result rarely stands alone. It usually comes with positivity for birch Bet v 1 and alder Aln g 1, and points to a broader tree pollen profile rather than a hazel-only allergy.

Tracking Your Trend Over Time

A single IgE reading is a snapshot, not a verdict. Levels can shift over time with ongoing pollen exposure, the natural waxing and waning of allergic disease, and with treatment such as allergen immunotherapy. Children, in particular, often develop new IgE reactivities to PR-10 proteins through the early school years, with patterns predicting later allergic rhinitis. Adults can also see shifts when they move regions, change their pet or pollen exposure, or undergo immunotherapy.

For active management, get a baseline now, especially before tree pollen season. If you start allergen immunotherapy or notice changing symptoms, retest in 6 to 12 months to see how your sensitization profile is evolving. A stable or rising specific IgE alongside worsening symptoms supports escalating treatment; a dropping value during effective immunotherapy is a reassuring sign of immune remodeling, though it is not the only useful marker because blocking IgG4 antibodies also rise and matter.

What an Unexpected Result Should Prompt You to Do

If your Cor a 1.0103 result is positive and you have spring respiratory symptoms or oral itching with raw fruits and nuts, the next step is usually to order companion components: birch Bet v 1, alder Aln g 1, and the hazelnut storage proteins Cor a 9 and Cor a 14. Together, these clarify whether your pattern is pollen-driven, food-driven, or a mix of both. A positive Cor a 1 with negative Cor a 9 and Cor a 14 is the classic profile for benign pollen-food syndrome. A positive Cor a 9 or Cor a 14 changes the conversation toward genuine nut allergy and warrants involvement of an allergist.

If you are positive for Cor a 1.0103 but have no symptoms, no immediate action is needed. The result tells you that you are sensitized but does not commit you to a diagnosis. Watch for new symptoms during tree pollen season or when eating raw apples, hazelnuts, or stone fruits, and consider an allergist visit if symptoms emerge. If symptoms are severe, sudden, or involve breathing or blood pressure, that is anaphylaxis territory and demands urgent in-person evaluation regardless of what any lab number says.

When Results Can Be Misleading

  • Cross-reactive interference: A positive result from a hazelnut extract panel can be inflated when the lab assay has been supplemented with recombinant Cor a 1. People with birch pollen allergy can show elevated hazelnut IgE values even though they tolerate hazelnut as a food. Component testing for Cor a 1.0103 specifically helps untangle this.
  • Asymptomatic sensitization: A positive result without symptoms is common and does not mean you have allergy. Sensitization and allergy are not the same thing.
  • Heat-treated foods: Because Cor a 1 breaks down with cooking, a positive test does not predict reactions to roasted hazelnuts, baked apples, or processed plant foods. The test reflects raw-food risk only.
  • Single timepoint variability: Allergen-specific IgE levels can drift over months. A borderline reading is best confirmed with a repeat test rather than acted on in isolation.

What Moves This Biomarker

Evidence-backed interventions that affect your Hazel Pollen (Cor a 1.0103) IgE level

Up & Down
Allergen immunotherapy for birch pollen (subcutaneous, SCIT)
This is the only treatment that genuinely remodels the immune response driving your hazel and birch pollen IgE. In birch-allergic adults receiving 3 years of subcutaneous immunotherapy, the seasonal allergy-driving Th2 response to Bet v 1 (birch's PR-10 protein, structurally near-identical to Cor a 1) was lost, and the body built up IgG antibodies that block IgE from binding allergen. Blocking activity peaked between 6 and 36 months and persisted after treatment ended. Birch-related food tolerance (including raw hazelnut) tracks with a rising Cor a 1-specific IgG4 to IgE ratio.
MedicationStrong Evidence
Increase
Intralymphatic immunotherapy (ILIT) with birch or grass pollen
ILIT delivers 3 injections of allergen directly into a lymph node and produces seasonal symptom reduction. In a placebo-controlled randomized trial of grass pollen ILIT, combined symptom and medication scores fell meaningfully during pollen season. Allergen-specific IgE typically rises initially rather than falls, but the IgG4 antibodies that develop have higher affinity, neutralizing the allergen before it can trigger your mast cells.
MedicationModerate Evidence
Increase
Sublingual immunotherapy (SLIT) for related pollen
Preseasonal SLIT in grass-allergic adults increased both allergen-specific IgE and IgG4, and reprogrammed B cell memory subsets that determine how your immune system responds to future pollen exposure. Symptoms improved despite the rise in IgE, because new blocking antibodies and tolerogenic T cells now compete with the IgE response.
MedicationModerate Evidence
Increase
Omalizumab (anti-IgE biologic) for seasonal hay fever
In a comparison of standard medication, omalizumab, and subcutaneous immunotherapy for hay fever, omalizumab and immunotherapy both allowed patients to be nearly medication-free during pollen season. Counterintuitively, pollen-specific and total IgE often rise on omalizumab because the drug binds free IgE into inactive complexes. The IgE molecule is still being measured, but it cannot trigger allergic reactions while bound.
MedicationModerate Evidence

Frequently Asked Questions

References

19 studies
  1. ČElakovská J, Bukac J, Cermakova E, Vankova R, Skalská H, Krejsek J, Andrys CInternational Journal of Molecular Sciences2021
  2. Siroux V, Lupinek C, Resch Y, Curin M, Just J, Keil T, Kiss R, Lødrup Carlsen KC, Mélen E, Nadif R, Pin I, Skrindo I, Vrtala S, Wickman M, Anto J, Valenta R, Bousquet JThe Journal of Allergy and Clinical Immunology2017
  3. Ott H, Schröder C, Stanzel S, Merk H, Baron JAllergy2006
  4. Ipsen H, Wihl J, Petersen BN, Løwenstein HClinical & Experimental Allergy1992
  5. Geroldinger-simić M, Zelniker TA, Aberer W, Ebner C, Egger C, Greiderer a, Prem N, Lidholm J, Ballmer-weber B, Vieths S, Bohle BThe Journal of Allergy and Clinical Immunology2011